Phosphodiesterase 4 Inhibitors
- Name
- Phosphodiesterase 4 Inhibitors
- Accession Number
- DBCAT001410
- Description
Compounds that specifically inhibit PHOSPHODIESTERASE 4.
- Drugs
Drug Drug Description Roflumilast A selective phosphodiesterase-4 inhibitor indicated to decrease the risk of exacerbations in patients with severe chronic obstructive pulmonary disease (COPD) and to treat skin conditions such as plaque psoriasis and atopic dermatitis. Piclamilast Piclamilast (RP-73,401), is a selective PDE4 inhibitor comparable to other PDE4 inhibitors for its anti-inflammatory effects. It has been investigated for its applications to the treatment of conditions such as... Rolipram A phosphodiesterase inhibitor with antidepressant properties. GSK-256066 Gsk256066 has been used in trials studying the treatment and diagnostic of SAR, Asthma, Mild Asthma, Allergic Rhinitis, and Seasonal Allergic Rhinitis, among others. E-6005 E6005 has been used in trials studying the treatment of Atopic Dermatitis. MK-0873 MK-0873 has been used in trials studying the treatment of Rheumatoid Arthritis. Cilomilast Investigated for use/treatment in chronic obstructive pulmonary disease (COPD). Crisaborole A non-steroidal topical medication used for the treatment of mild-moderate atopic dermatitis. Apremilast A non-steroidal medication used for the treatment of inflammatory conditions such as psoriasis and psoriatic arthritis. Drotaverine A phosphodiesterase-4 inhibitor used to alleviate gastrointestinal and genitourinary smooth muscle spasms. Dovramilast Dovramilast is under investigation in clinical trial NCT01300208 (To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus... Zatolmilast BPN-14770 is under investigation in clinical trial NCT02840279 (A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects). Ensifentrine A phosphodiesterase inhibitor used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. - Drugs & Drug Targets